Medicare Enrolled

Dr. Philip Aschi, DO

Urology Physician · Wilmington, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
781 W LOCUST ST, Wilmington, OH 45177
9372832560
In practice since 2006 (19 years)
NPI: 1467463695 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aschi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aschi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aschi

Dr. Philip Aschi is an urology physician in Wilmington, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aschi performed 2,184 Medicare services across 1,522 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aschi received a total of $11,307 from 38 pharmaceutical and/or device companies across 328 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aschi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in OH $11,307 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,184
Medicare services
Top 26% in OH for urology physician
1,522
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
537 $86 $221
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
342 $57 $150
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
282 $8 $10
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
234 $3 $23
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
175 $98 $340
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
162 $7 $39
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
99 $165 $407
Simple change of bladder tube 93 $68 $186
Additional urethral implant in prostate
Placement of an additional implant into the urethra within the prostate gland using an endoscope.
65 $39 $1,868
Electronic analysis of implanted neurostimulator
This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation.
32 $36 $104
Sacral nerve stimulator electrode insertion
A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves.
29 $266 $1,806
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
29 $13 $138
Urethral implant insertion in prostate
A single implant is placed into the urethra within the prostate gland using an endoscope.
22 $153 $2,585
Insertion of peripheral or gastric neurostimulator generator
A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach.
20 $65 $519
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $34 $89
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
15 $16 $41
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
15 $61 $152
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
14 $100 $486
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,307
Total received (2018-2024)
Avg $1,615/year across 7 years
Top 15% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
328
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,947 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$360 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,575
2023
$2,217
2022
$1,589
2021
$1,725
2020
$674
2019
$1,662
2018
$1,865

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$878
Medtronic, Inc.
$476
Sumitomo Pharma America, Inc.
$135
Laborie Medical Technologies Corp.
$24
Antares Pharma, Inc.
$22
Teleflex LLC
$21
PROGENICS PHARMACEUTICALS, INC.
$20
Top 3 companies account for 94.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$3,031
Medtronic, Inc.
$1,260
BOSTON SCIENTIFIC CORPORATION
$1,139
NeoTract Inc.
$1,116
Astellas Pharma US Inc
$909
Medtronic USA, Inc.
$761
Teleflex LLC
$690
Sumitomo Pharma America, Inc.
$408
Tosoh Bioscience, Inc.
$220
Antares Pharma, Inc.
$217
Endo Pharmaceuticals Inc.
$203
Janssen Biotech, Inc.
$176
Palette Life Sciences, Inc.
$162
Coloplast Corp
$153
Laborie Medical Technologies Corp.
$137
Progenics Pharmaceuticals, Inc.
$124
Myovant Sciences Inc.
$110
AbbVie, Inc.
$76
PFIZER INC.
$37
Aytu BioScience, Inc
$37
Ferring Pharmaceuticals Inc.
$31
AKRIMAX PHARMACEUTICALS, LLC
$27
Telix Pharmaceuticals
$24
Dendreon Pharmaceuticals LLC
$23
Axonics Modulation Technologies, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
PROGENICS PHARMACEUTICALS, INC.
$20
Merck Sharp & Dohme Corporation
$19
Merck Sharp & Dohme LLC
$18
COLOPLAST CORP
$17
Blue Earth Diagnostics Limited
$17
Acerus Pharmaceuticals Corporation
$16
Egalet US Inc
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Allergan Inc.
$14
Accord Healthcare, Inc.
$14
Axonics, Inc.
$12
Clarus Therapeutics Inc.
$11
Top 3 companies account for 48.0% of all-time payments
Associated products mentioned in payments ›
25-OH Vitamin D ST AIA-Pack · ADVANCE · AIA-PACK · AMBICOR · AMS 700 · AVEED · Altis · Androgel · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · EDEX · EMS SWISS LITHOCLAST TRIOLOGY · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL - ERECTILE DYSFUNCTION · GENERAL - THERAPIES · GENERAL ERECTILE DYSFUNCTION · GREENLIGHT · General - Erectile Dysfunction · ILLUCCIX · INTERSTIM · JATENZO · KEYTRUDA · LITHOCLAST · LITHOVUE · LithoVue · Lumenis Pulse 120H · Lupron Depot · MYRBETRIQ · Moses 550 DFL · NOCDURNA · Natesto · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PROVENGE · PYLARIFY · Rezum Generator · SPRIX · ST · SWISS LITHOCLAST TRILOGY · Stendra · Swiss LithoClast Triology · TITAN · TOVIAZ · TU · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xpeeda DSL Fiber
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Wilmington?
Compare urology physicians in the Wilmington area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
24
Per 100K population
57.1
County median income
$68,125
Nearest hospital
CLINTON MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aschi is a clinical cardiology specialist, with above-average Medicare volume (top 26% in OH), with low-engagement industry engagement in the top 15% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aschi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aschi performed 537 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aschi receive payments from pharmaceutical companies?
Yes. Dr. Aschi received a total of $11,307 from 38 companies across 328 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aschi's costs compare to other urology physicians in Wilmington?
Dr. Aschi's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aschi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →